Type I Interferons (IFN-Is) protect against early HIV infection, but were linked to pathogenesis during the chronic stages. Previously, we showed that IFNβ, but not IFNα, was upregulated in the colon of chronically infected people with HIV (PWH) relative to uninfected persons (PMID29762170). To gain understanding on how IFNβ may influence chronic gut HIV pathogenesis, we profiled the transcriptome of uninfected gut CD4 T cells exposed to dominant IFNα subtypes or IFNβ in vitro. This analysis revealed a set of IFN-stimulated genes (ISGs) upregulated by all IFN-Is tested (core ISGs) and genes specifically induced by IFNβ (βISGs). Here, we evaluated these 2 gene sets in chronic, untreated HIV-1 infection.
Colon biopsies (previously collected with informed consent) from 19 untreated, chronically infected PWH (median VL 26000 HIV-1 RNA/ml; median CD4 count 429 cells/μl) and 13 uninfected controls were transcriptomically profiled using RNAseq. Differential gene analysis was conducted using edgeR and correlations between ISGs and clinical/immunological parameters tested using linear regression models adjusted for age and gender and corrected for multiple comparisons. Significance was established at FDR <5% for all analyses.
Of 246 core ISGs, 51% were significantly altered in PWH vs. controls. Of these 126 altered core ISGs, 89% were upregulated in PWH. Upregulated core ISGs included genes linked to innate sensing (e.g. IRF9 3.9x; NLRC5 3.5x), immune activation (e.g. CD38 2.4x) and exhaustion (e.g. LAG3 6.2x). Majority (78%) of altered core ISGs positively correlated with gut IFNβ transcripts and plasma LPS levels and inversely with gut CD4 T cell frequencies. Of 406 βISGs, 28% were significantly altered in PWH. Of these 112 altered βISGs, >90% were downregulated in PWH and included genes linked to anti-inflammatory responses (e.g. SMAD4 -1.5x) and maintaining genomic DNA integrity (e.g. NUP54 -1.6x, MUS81 -1.6x). In contrast to the core ISGs, majority (85%) of altered βISGs inversely correlated with IFNβ and LPS levels, and 50% positively correlated with gut CD4 T cell frequencies.
Our data reveals a complex picture of how IFNβ may promote HIV pathogenesis in the gut. While IFNβ is associated with increased core ISG expression linked to inflammation, immune activation and exhaustion, it is also linked to decreased expression of genes with potential anti-inflammatory properties. These data could guide IFN-I blockade strategies to reduce chronic inflammation in PWH.